Adipose-Derived Stem Cells (ADSCs) Injections for Liver Cirrhosis
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Jul 2017
At a glance
- Drugs GXHPC 1 (Primary)
- Indications Liver cirrhosis
- Focus Therapeutic Use
- Sponsors GWOXI Stem Cell Applied Technology
- 04 Jul 2017 Planned End Date changed from 1 Sep 2017 to 31 Jan 2018.
- 04 Jul 2017 Planned primary completion date changed from 1 Jul 2017 to 4 Jul 2017.
- 04 Jul 2017 Status changed from recruiting to active, no longer recruiting.